Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 89
Healthy Volunteers: t
View:
• Foregut procedures
Locations
United States
Washington
Madigan Army Medical Center
RECRUITING
Tacoma
Contact Information
Primary
Brooklyn Williams, DO
brooklyn.c.williams3.mil@health.mil
(253) 968-3105
Backup
Christopher Porta, MD
christopher.r.porta.civ@health.mil
(253) 968-3105
Time Frame
Start Date: 2025-04-08
Estimated Completion Date: 2029-03
Participants
Target number of participants: 260
Treatments
Placebo_comparator: Control Arm
This arm will receive the placebo pill
Experimental: Experimental Arm
This arm will receive simethicone
Related Therapeutic Areas
Sponsors
Leads: Madigan Army Medical Center